Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 27 results.
User Information
Export Records
  1. 1.   Naamidine A reveals a promising zinc-binding strategy for topical antifungal therapy
  2. Puumala, Emily; Nabeela, Sunna; Thornburg,Chris; Grkovic,Tanja; Uppuluri, Priya; Whitesell, Luke; O'Keefe,Barry; Robbins, Nicole; Cowen, Leah E
  3. Antimicrobial Agents and Chemotherapy. 2024, Sep 26; e0119424.
  1. 2.   A Practical Approach to Bicyclic Carbamoyl Pyridones with Application to the Synthesis of HIV-1 Integrase Strand Transfer Inhibitors
  2. Mahajan,Pankaj; Smith,Steven; Hughes,Stephen; Zhao,Xue Zhi; Burke,Terrence
  3. Molecules (Basel, Switzerland). 2023, Feb 02; 28(3):
  1. 3.   The Proteasome Ubiquitin Receptor hRpn13 and Its Interacting Deubiquitinating Enzyme Uch37 Are Required for Proper Cell Cycle Progression
  2. Randles, L.; Anchoori, R. K.; Roden, R. B.; Walters, K. J.
  3. The Journal of biological chemistry. 2016, 15-Apr; 291(16): 8773-83.
  1. 4.   Biological evaluation of imidazolium- and ammonium-based salts as HIV-1 integrase inhibitors
  2. Maddali, K.; Kumar, V.; March, C.; Pommier, Y.; Malhotra, S. V.
  3. Medchemcomm. 2011, Feb; 2(2): 143-150.
  1. 5.   A copper chelate of thiosemicarbazone NSC 689534 induces oxidative/ER stress and inhibits tumor growth in vitro and in vivo
  2. Hancock, C. N.; Stockwin, L. H.; Han, B. N.; Divelbiss, R. D.; Jun, J. H.; Malhotra, S. V.; Hollingshead, M. G.; Newton, D. L.
  3. Free Radical Biology and Medicine. 2011, Jan; 50(1): 110-121.
  1. 6.   Tautomerism and Magnesium Chelation of HIV-1 Integrase Inhibitors: A Theoretical Study
  2. Liao, C. Z.; Nicklaus, M. C.
  3. Chemmedchem. 2010, Jul 5; 5(7): 1053-1066.
  1. 7.   A profile of the in vitro anti-tumor activity of imidazolium-based ionic liquids
  2. Malhotra, S. V.; Kumar, V.
  3. Bioorganic & Medicinal Chemistry Letters. 2010, Jan; 20(2): 581-585.
  1. 8.   Development of a cell-based assay to quantify the inflammatory potential of test substances and screen compound libraries for anti-cancer drug candidates in a high-throughput format
  2. Kozlov, S. V.
  3. Methods in molecular biology (Clifton, N.J.). 2009 512: 159-167.
  1. 9.   Study on the potential anti-cancer activity of phosphonium and ammonium-based ionic liquids
  2. Kumar, V.; Malhotra, S. V.
  3. Bioorganic & Medicinal Chemistry Letters. 2009 19(16): 4643-4646.
  1. 10.   Improved titanium dioxide enrichment of phosphopeptides from HeLa cells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra
  2. Yu, L. R.; Zhu, Z. Y.; Chan, K. C.; Issaq, H. J.; Dimitrov, D. S.; Veenstra, T. D.
  3. Journal of Proteome Research. 2007, Nov; 6(11): 4150-4162.
  1. 11.   Sphingolipids, cholesterol, and HIV-1: A paradigm in viral fusion
  2. Rawat, S. S.; Viard, M.; Gallo, S. A.; Blumenthal, R.; Puri, A.
  3. Glycoconjugate Journal. 2006, MAY; 23(3-4): 189-197.
  1. 12.   CB694, a novel antimitotic with antitumor activities
  2. Weiderhold, K. N.; Randall-Hiubek, D. A.; Polin, L. A.; Hamel, E.; Mooberry, S. L
  3. International Journal of Cancer. 2006, FEB 15; 118(4): 1032-1040.
  1. 13.   TRAF2 plays a key, nonredundant role in LIGHT-lymphotoxin beta receptor signaling
  2. Kim, Y. S.; Nedospasov, S. A.; Liu, Z. G.
  3. Molecular and Cellular Biology. 2005, MAR; 25(6): 2130-2137.
  1. 14.   Dynamic fluorescent imaging of human immunodeficiency virus type 1 Gag in live cells by biarsenical labeling
  2. Rudner, L.; Nydegger, S.; Coren, L. V.; Nagashima, K.; Thali, M.; Ott, D. E.
  3. Journal of Virology. 2005 79(7): 4055-4065.
  1. 15.   Anticancer metal compounds in NCI's tumor-screening database: putative mode of action
  2. Huang, R. L.; Wallqvist, A.; Covell, D. G.
  3. Biochemical Pharmacology. 2005 69(7): 1009-1039.
  1. 16.   Coordination mode and oxidation susceptibility of nickel(II) complexes with 2 '-deoxyguanosine 5 '-monophosphate and L-histidine
  2. Jezowska-Bojczuk, M.; Kaczmarek, P.; Bal, W.; Kasprzak, K. S.
  3. Journal of Inorganic Biochemistry. 2004, NOV; 98(11): 1770-1777.
  1. 17.   Novel protein-protein interactions of the Yersinia pestis type III secretion system elucidated with a matrix analysis by surface plasmon resonance and mass spectrometry
  2. Swietnicki, W.; O'Brien, S.; Holman, K.; Cherry, S.; Brueggemann, E.; Tropea, J. E.; Hines, H. B.; Waugh, D. S.; Ulrich, R. G.
  3. Journal of Biological Chemistry. 2004, SEP 10; 279(37): 38693-38700.
  1. 18.   Regulation of HDM2 activity by the ribosomal protein L11
  2. Lohrum, M. A. E.; Ludwig, R. L.; Kubbutat, M. H. G.; Hanlon, M.; Vousden, K. H.
  3. Cancer Cell. 2003 3(6): 577-587.
  1. 19.   O-6-benzylguanine-mediated enhancement of chemotherapy
  2. Friedman, H. S.; Keir, S.; Pegg, A. E.; Houghton, P. J.; Colvin, O. M.; Moschel, R. C.; Bigner, D. D.; Dolan, M. E.
  3. Molecular Cancer Therapeutics. 2002 1(11): 943-948.
  1. 20.   Phase II trial of carmustine plus O-6-benzylguanine for patients with nitrosourea-resistant recurrent or progressive malignant glioma
  2. Quinn, J. A.; Pluda, J.; Dolan, M. E.; Delaney, S.; Kaplan, R.; Rich, J. N.; Friedman, A. H.; Reardon, D. A.; Sampson, J. H.; Colvin, O. M.; Haglund, M. M.; Pegg, A. E.; Moschel, R. C.; McLendon, R. E.; Provenzale, J. M.; Gururangan, S.; Tourt-Uhlig, S.; Herndon, J. E.; Bigner, D. D.; Friedman, H. S.
  3. Journal of Clinical Oncology. 2002 20(9): 2277-2283.
  1. 21.   The role of NF-kappa B in the regulation of cell stress responses
  2. Wang, T. L.; Zhang, X.; Li, J. J.
  3. International Immunopharmacology. 2002 2(11): 1509-1520.
  1. 22.   Effector genes altered in MCF-7 human breast cancer cells after exposure to fractionated ionizing radiation
  2. Li, Z. K.; Xia, L. Q.; Lee, L. M.; Khaletskiy, A.; Wang, J. Y.; Wong, J. Y. C.; Li, J. J.
  3. Radiation Research. 2001 155(4): 543-553.
  1. 23.   Phase I trial of carmustine plus O-6-benzylguanine for patients with recurrent or progressive malignant glioma
  2. Friedman, H. S.; Pluda, J.; Quinn, J. A.; Ewesuedo, R. B.; Long, L.; Friedman, A. H.; Cokgor, I.; Colvin, O. M.; Haglund, M. M.; Ashley, D. M.; Rich, J. N.; Sampson, J.; Pegg, A. E.; Moschel, R. C.; McLendon, R. E.; Provenzale, J. M.; Stewart, E. S.; Tourt-Uhlig, S.; Garcia-Turner, A. M.; Herndon, J. E.; Bigner, D. D.; Dolan, M. E.
  3. Journal of Clinical Oncology. 2000 18(20): 3522-3528.
  1. 24.   Crystal structure of RNA 3 '-terminal phosphate cyclase, a ubiquitous enzyme with unusual topology
  2. Palm, G. J.; Billy, E.; Filipowicz, W.; Wlodawer, A.
  3. Structure with Folding & Design. 2000 8(1): 13-23.
  1. 25.   Influenza virus-assisted entry of a TCL-tropic HIV-1 isolate into CD4+ cells
  2. Puri, A.; Carroll, R.; Riley, J.; Hug, P.; Jernigan, K.; Blumenthal, R.
  3. Keystone Symposia on Molecular and Cellular Biology. 1998, 114 (abstract no. 109).
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel